Category: Corcept
-
Corcept therapeutics exec sells $509k in stock, buys options By Investing.com
•
Investor EmpiresIn one of the recent deals, Gary Charles Robb, Chief Business Officer at… Corcept Treatments (NASDAQ:), sold shares of the company’s common stock for a total value of approximately $509,080. The sale, dated October 1, 2024, included 11,000 shares at an average price of $46.28 per share. This move coincides…